PharmaCyte Biotech Inc (PMCB)

[urup]

“It is my firm belief the Cell-in-a-Box technology will prove to be of great value for the development of treatments for pancreatic and other cancers, and its possible role in a treatment for insulin-dependent diabetes is particularly intriguing. It is a pleasure to chair Pharmacyte’s Scientific Advisory Board. I look forward to working with the Pharmacye team to help bring this important technology to fruition,” commented Dr. Lohr.


http://www.bloomberg.com/research/stocks/private/person.asp?personId=22366657&privcapId=22337975&previousCapId=22337975&previousTitle=LB%2520GmbH

http://globenewswire.com/news-release/2014/10/06/670875/10101314/en/Nuvilex-Appoints-Dr-Matthias-Lohr-as-Chairman-of-Scientific-Advisory-Board.html